Table 3.
Societal Perspective Incremental Cost-Effectiveness Ratio of Oncotype Testing in Community Practice Versus Usual Care Without Testing Among Patients With Stage I or II, Node-Negative, ER-Positive, HER2-Negative Breast Cancer
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.